Kalytera Announces Binding Agreement to Acquire Salzman Group
Hit enter to search or ESC to close
Kalytera Therapeutics, Inc.
  • Investors
    • Investor Overview
    • Press Releases
    • Company Information
    • SEDAR Filings
    • SEC Filings
    • Stock Information
    • Corporate Governance
  • Contact
  • Investors
    • Investor Overview
    • Press Releases
    • Company Information
    • SEDAR Filings
    • SEC Filings
    • Stock Information
    • Corporate Governance
  • Contact
Category

Media Mentions

Kalytera In Media Mentions

Prescription Drug Prices Climb Over 10 Percent in 2015 [Pharmaceutical Processing]

http://www.pharmpro.com/news/2016/01/prescription-drug-prices-climb-over-10-percent-2015
Kalytera In Media Mentions

DEA Eases Restrictions on CBD Research to Benefit Big Pharma [HighTimes]

http://www.hightimes.com/read/dea-eases-restrictions-cbd-research-benefit-big-pharma
Kalytera In Media Mentions

DEA Eases Cannabis Study Requirements [Forbes]

http://www.forbes.com/sites/debraborchardt/2015/12/24/dea-eases-cannabis-study-requirements/
Kalytera In Media Mentions

The Outsourcing of American Marijuana Research [Newsweek]

http://www.newsweek.com/2015/12/25/outsourcing-american-marijuana-research-406184.html
Kalytera In Media Mentions

Three Make The Jump From Wall Street To Cannabis Startups And Tell Us What It’s Like [Forbes]

http://www.forbes.com/sites/julieweed/2015/11/14/whats-it-like-to-move-from-wall-street-to-a-cannabis-start-up-three-execs-let-us-know/
Kalytera In Media Mentions

Some doctors uneasy about medical marijuana [Illinois Times]

http://illinoistimes.com/article-16406-some-doctors-uneasy-about-medical-marijuana.html
Kalytera In Media Mentions

In Development: Cannabidiol Treatments [Pharmaceutical Processing]

http://www.pharmpro.com/articles/2015/11/development-cannabidiol-treatments
Previous 1 2 3
Get Email Alerts Subscribe

New Website Coming Soon


© 2020 Kalytera Therapeutics, Inc.

Kalytera Announces Binding Agreement to Acquire Salzman Group
  • Investors
    • Investor Overview
    • Press Releases
    • Company Information
    • SEDAR Filings
    • SEC Filings
    • Stock Information
    • Corporate Governance
  • Contact

© 2016 Kalytera Therapeutics, Inc.